FDA Authorizes New Covid Boosters Aimed at Omicron Subvariants
FDA Authorizes New Covid Boosters Aimed at Omicron Subvariants
The FDA authorized newly modified Covid-19 boosters to target the latest versions of the Omicron variant. But, as WSJ’s Daniela Hernandez explains, a key part of the decision-making process was changed with these new shots. Photo: Laura Kammermann
3:10
Daniela Hernandez
Daniela Hernandez extends her health and science reporting to cover a variety of relevant subjects from Covid-19 to climate change.